Americans are waking up to the fact that we’ve been tolerating unacceptable failure rates for drugs that are supposed to be safe and effective.
Featuring:
– Reshma Ramachandran, M.D., Assistant Professor of Medicine and Co-Director of Yale CRRIT, Yale School of Medicine
– Marta Wosińska, Ph.D., Senior Fellow, Center on Health Policy, The Brookings Institution
– Emma Yasinski, Senior Reporter, MedShadow Foundation (moderator)
Join this discussion that examines the changes and incentives needed to improve the drug system’s quality control and supply chains, and ensure everyone can access safe, reliable generic drugs.




If you feel like your generic drugs aren’t working, you may be right. Generics don’t alway...
Low-quality generics are being sold at U.S. pharmacies, despite the FDA’s best efforts. In...
We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.
We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.
As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.
No comments yet. Be the first to comment!